Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19
Elizabeth Leung, Ryan L. Crass, Sarah C J Jorgensen, Sumit Raybardhan, Bradley J. Langford, William J Moore, Nathaniel J. Rhodes
Topics & Concepts
TocilizumabDosingMedicinePharmacodynamicsPharmacokineticsPharmacologyCoronavirus disease 2019 (COVID-19)Intensive care medicineInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAntibiotics Pharmacokinetics and Efficacy